Objectives
Neurological complications are reported in 13-47% of patients after orthotopic liver transplantation (LT). 1, 2 Our hypothesis was adult chronic liver disease (CLD) patients unlike the pediatric group have preexisting sub clinical neurologic damages which were aggravated by antiplatelet medications. Whether aspirin was effective in preventing hepatic artery thrombosis (HAT)? Whether neurological complications were attributable to aspirin? Was aspirin effective in preventing HATs? Were the aims of our study. We have analyzed the neurological complications (NC) post-living donor liver transplantation (LDLT) and the association of aspirin use in over 1400 cases over a period of eight years. Antiplatelet agents (aspirin and or clopidogrel) are routinely used in the postoperative period as prophylaxis against hepatic artery thrombosis in various liver transplantation centers across the world. Previously the incidence of HAT was 5-15% across centers all over the world. Risk was relatively high in pediatric group of population. Hence the use of antiplatelet agents routinely in post-operative period. Still many centers across the world continue to do so. We observed that there was increase in the incidence of neurological complications in the aspirin group (AG). Hence we stopped using aspirin routinely in adults as HAT prophylaxis in the post-operative period. We found that there was no increase in the incidence of HAT and also there was decrease in the neurological complications in the non-aspirin group (NAG).
Materials and methods
It was a case control study. Total number of cases studied were Aspirin used in the post-operative period as prophylaxis for hepatic artery thrombosis (HAT) increases the risk of neurological complications (NC) in adult living donor liver transplantation (LDLT) recipients was the hypothesis. Case control study was done on 1400 cases operated in our institute. Pediatric transplants, combined liver kidney, cadaver transplants, dual lobe transplants, preexisting organic neurological dysfunction and patients whose records were missing were excluded from the study. There were effectively 880 cases in non-aspirin group (NAG) and 440 cases in aspirin group (AG). The groups were matched for various factors. There were more alcoholics in AG and more ALFs in NAG. On subgroup analysis these two etiological factors were found to be statistically insignificant P > 0.05. So the prophylactic protocol was aspirin 75 mg once daily in all adults (age >12 years) once the platelet counts have reached 50,000 and there is no evidence of bleeding elsewhere. In pediatric population our protocol is use of aspirin 75 mg and clopidogrel 75 mg once daily once the platelet counts have reached 50,000 and there is no evidence of bleeding anywhere else.
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to be statistically insignificant. There was significant difference in NC, WIT and hospital stay between the two groups. We further analyzed the neurological complication population of both groups separately. On subgroup analysis of AGNC and NAGNC we again found that WIT and hospital stay (HS) were prolonged. Hence we concluded that these were surrogate markers of our improvements in surgical technique and postoperative protocols over a period of time (learning curve). CIT and HS could well be the associated effect or cause of NCs. These parameters could not be analyzed further in this study. However on further subgroup analysis of NCs there was statistically significant increase in the neuropsychiatric manifestations and seizures in AG compared to the NAG. Conversely aspirin neither did increase the incidence of HAT nor did decrease the intracranial vascular complications. The statististical analysis between AG and NAG are given in Table 1 . Subgroup analysis between the two groups based on the neurological complications AGNC and NAGNC is summarized in Table 2 .
Discussion
Both the groups were matched for various parameters as listed in Table 1 . There was statistically significant difference of NCs, HS, WIT, alcoholic CLDs and acute liver failure (ALF) between two groups. More ALFs in NAG. ALF and alcoholism were further matched intergroup and intragroup and found to be statistically insignificant in causing NCs. HS and WIT were found to be high in all patients in the AG compared to the NAG. This gradual improvement in the WIT in the NAG may be secondary to refinements in surgical technique secondary to learning curve. Decrease in HS in the population in the later period of the study implies standardized post-operative protocols. Over the years we have avoided using wide bore drains which was one of the main culprits for prolonged hospital stay. Patients are fed early and ambulated early. Drains are removed by 10th post-operative day. Hence we were able to cut down on the hospital day by almost 10 days. We were not able to negate the cause effect of these two parameters on the NCs scientifically by this study. The neurological complications between the two subgroups were discussed under nine subheadings and are also summarized in Table 2 .
Hemorrhage and infarcts
Acute cerebrovascular disorders occur in 2-6.5% of LT recipients, mostly with cerebral hemorrhage, usually within 2 months after surgery. [3] [4] [5] There was 12% in AG and 16% in NAG. There was no statistical difference in the significance. They definitely add to the morbidity. Few of them required neurosurgical intervention for evacuation for clots to reduce the intracranial tension. Altered higher functions lead to increased need for nursing care and nutritional support. These group of patients require prolonged ventilation and tracheostomy along with associated lung complications. Adjustment of cerebrovascular risk factors before, during, and after LT is the main preventive measure. Diagnosis and treatment are similar to those adopted in the general population. Attention is paid to the search for infection as a cause of acute cerebrovascular disorders, in order to institute prompt systemic antibiotic/antifungal therapy once infection occurs, especially in elderly patients. 4,5
Mononeuropathies
Neuromuscular disorders present with focal or generalized weakness. 3 Focal weakness Includes Mononeuropathies, with an incidence of 2-13%, and brachial plexopathy (1-5.8%). Axonal involvement is common. Invasive procedures, perioperative positioning and rarely medications are found to be causative factors. Various mononeuropathies noted in our study were isolated limb palsies, vocal cord palsy, optic neuritis and hearing impairment. There was no significant difference in the incidence between two groups. Isolated limb palsies included upper limb and lower limb monoplegia. The incidence was slightly higher in the NAG.
Seizures
Seizures occur in 0-40% of LT recipients, 3,6,7 with a tendency to lower numbers in the more recent reports. Most are generalized tonic-clonic seizures. Convulsive or non-convulsive status epilepticus is rare. Seizures occur most often early after surgery, due to drugs, acute metabolic derangement, hypoxic-ischemic injury, cerebral lesions, sudden withdrawal of narcotic agents, or inadvertent discontinuation or changes in anticonvulsant drugs in patients with epilepsy. Immunosuppressant toxicity is the main etiology. 3 They were the second most common cause of neurological complications. Post-transplant seizures are common. In our series it was 15%. There are multiple reasons. They may be secondary to electrolyte imbalances, tacrolimus toxicity, infective CNS problems and vascular events. Here we analyzed the sub group of population which had isolated seizures where no cause could be made out after detailed neurological evaluation including CT and MR brain and or lumbar puncture when needed. There was statistically significant increase in the incidence of seizures in AG. They may either correlate with transient vascular events which were not significant enough to produce radiological changes. All these patients were placed on 3 months antiseizure prophylaxis.
Neuropsychiatric manifestations
They emerged as the commonest neurological complications in both groups. Chronic progressive hepatocerebral degeneration with spastic paraparesis, dementia, dysarthria, ataxia, tremor, and neuropsychiatric symptoms follows long-standing portal-systemic shunting and is associated with structural changes in the central nervous system, and does not respond to conventional therapy for hepatic encephalopathy. Those patients were managed with antipsychotic medications after evaluation by neurologist and psychiatrists. They did not require antiepileptic prophylaxis. Their improvement in symptoms correlated with recovery. The higher incidence in aspirin era may be secondary to higher incidence of morbidities and prolonged hospital stay in that era.
Central pontine myelinolysis (CPM)
CPM is usually seen in alcoholic and malnourished patients, attributed to a rapid correction of hypernatremia. CPM has been reported in 1-8% of LT recipients. 8 The high incidence in LT is likely to be favored by the usual hyponatremic state of patients with cirrhosis and by the large replacement of fluids during the operation, leading to a sharp increase in plasma levels of sodium. CPM occurs early after surgery. The clinical picture can vary considerably from paucisymptomatic pictures to misleading presentations or severe signs characterized by dysarthria, paraparesis, or quadriparesis. 8 A high mortality rate has been reported. 9,10 CPM is usually seen in alcoholic and malnourished patients, attributed to a rapid correction of hypernatremia. CPM has been reported in 1-8% of LT recipients. 8 The high incidence in LT is likely to be favored by the usual hyponatremic state of patients with cirrhosis and by the large replacement of fluids during the operation, leading to a sharp increase in plasma levels of sodium. CPM occurs early after surgery. The clinical picture can vary considerably from paucisymptomatic pictures to misleading presentations or severe signs characterized by dysarthria, paraparesis, or quadriparesis. 8 Our protocol is to take the patients for surgery only when the serum sodium is more than 125 mmol/ patients with sodium less than the lower limit are rejected. Enough care is taken by the anesthesia team to prevent rapid correction of hypernatremia. Severely hyponatremic patients were managed with tolvaptan which rapidly corrects the serum sodium levels by promoting water diuresis. MRI is the investigation of choice. Contrary to the world literature there was no mortality in our patients. Of course it definitely increased the other morbidities and hospital stay.
Tacrolimus intolerance
This is a cohort of patients who develop intolerance to the drug at therapeutic or sub therapeutic levels in the form of vague neuropsychiatric symptoms. Predominant symptoms included nausea, vomiting, vague abdominal pain and dizziness. These group of patients responded to switching the immunosuppressant to cyclosporine. This group is not to be confused with TAC toxicity where neurological symptoms secondary to high tacrolimus levels which responded to withholding few doses of tacrolimus.
Infective neurological complications
Infective neurological complications in our study included brain abscess, fungal endophthalmitis. None in the aspirin era whereas 4 in no aspirin era. Though there were more infective complications in NAG these findings seems to be incidental. No cause effect relationship could be found between aspirin and CNS infections in the literature. CNS infections in LT recipients are favored by immunosuppression, the incidence being estimated to reach 5% with a high mortality. 11, 12 
Prolonged ventilation
Usually almost 99% of our patients are off ventilator after 24 h from surgery. Sometimes very stable patients are intubated on table also. Slightly delayed extubation is common in ALF group of patients. But we had one patient who was a non-ALF patient on prolonged ventilation for 7 days and then he had relatively normal recovery after extubation.
HAT
HAT incidence in our series was 1.5% in AG and 0.5% in NAG. This very important statistical analysis proves that there is no substitute to best surgical technique in preventing the incidence of arterial thrombosis. The results are one of the best for any transplant center across the globe.
Pediatric population
None of the pediatric patients in the aspirin + clopidogrel era had neurological complications. Two children in the post-aspirin era had hemorrhagic neurological complications. In the postaspirin era, one was on aspirin + clopidogrel the other was on aspirin alone, both of them recovered well. One child had neuropsychiatric manifestations which responded to switch over from tacrolimus to neural. One child with Gaucher's disease had metabolic encephalopathy and failed to wake up from surgery. The child was on prolonged ventilator support and finally succumbed to ventilator associated complications. There were total of 2 HATs in pediatric population with the incidence of 2.5% one in the aspirin + clopidogrel era and another in the aspirin alone era. Hence we continue to use aspirin in all post-transplant pediatric population and clopidogrel in selected patients.
Conclusion
There was statistically significant increase in the neurological complications with aspirin use. Other confounding variables like prolonged WIT and prolonged hospital stay could not be categorically excluded as covariables of cause of neurological complications. Further studies are needed.
Aspirin was not effective in preventing HAT in adult population. Hence the prophylactic protocol was aspirin 75 mg once daily in all adults (age >12 years) once the platelet counts have reached 50,000 and there is no evidence of bleeding elsewhere. In pediatric population our protocol is use of aspirin 75 mg and clopidogrel 75 mg once daily once the platelet counts have reached 50,000 and there is no evidence of bleeding anywhere else. After observing that our HAT incidence was very low we stopped using aspirin in adults and clopidogrel in pediatric population from 01/4/2011.
Presently our adult patients are not on aspirin and pediatric population is on aspirin 75 mg once daily for 3 months posttransplantation, high risk pediatric population is given clopidogrel for 3 weeks.
